CLEARBRIDGE VARIABLE AGGRESSIVE GROWTH PORTFOLIO

Schedule of investments (unaudited) March 31, 2023

(Percentages shown based on Portfolio net assets)

SECURITY	SHARES		VALUE
COMMON STOCKS - 98.6%
COMMUNICATION SERVICES - 15.8%
Entertainment - 6.4%
Liberty Media Corp.-Liberty Formula One, Class C Shares		25,556	$	1,912,356	*
Madison Square Garden Entertainment Corp.		32,871		1,941,690	*
Madison Square Garden Sports Corp.		23,864		4,649,900
Warner Bros. Discovery Inc.		81,688		1,233,489	*
World Wrestling Entertainment Inc., Class A Shares		10,301		940,069
Total Entertainment				10,677,504
Interactive Media & Services - 2.1%
Match Group Inc.		41,844		1,606,391	*
Meta Platforms Inc., Class A Shares		9,234		1,957,054	*
Total Interactive Media & Services				3,563,445
Media - 7.3%
AMC Networks Inc., Class A Shares		29,048		510,664	*
Comcast Corp., Class A Shares		245,641		9,312,250
Liberty Broadband Corp., Class A Shares		6,225		511,197	*
Liberty Broadband Corp., Class C Shares		12,131		991,103	*
Liberty Media Corp.-Liberty SiriusXM, Class C Shares		36,634		1,025,385	*
Total Media				12,350,599
TOTAL COMMUNICATION SERVICES				26,591,548
CONSUMER DISCRETIONARY - 3.8%
Broadline Retail - 2.1%
Etsy Inc.		32,182		3,582,822	*
Hotels, Restaurants & Leisure - 1.7%
Airbnb Inc., Class A Shares		23,329		2,902,128	*
TOTAL CONSUMER DISCRETIONARY				6,484,950
CONSUMER STAPLES - 1.7%
Beverages - 1.7%
Diageo PLC, ADR		15,927		2,885,654
FINANCIALS - 1.6%
Capital Markets - 1.6%
Cohen & Steers Inc.		41,106		2,629,140
HEALTH CARE - 28.8%
Biotechnology - 16.2%
AbbVie Inc.		24,595		3,919,705
Biogen Inc.		21,378		5,943,725	*
Ionis Pharmaceuticals Inc.		59,698		2,133,607	*

See Notes to Schedule of Investments.

ClearBridge Variable Aggressive Growth Portfolio 2023 Quarterly Report         1

CLEARBRIDGE VARIABLE AGGRESSIVE GROWTH PORTFOLIO

Schedule of investments (unaudited) (cont’d) March 31, 2023

(Percentages shown based on Portfolio net assets)

SECURITY	SHARES		VALUE
Biotechnology - continued
Ultragenyx Pharmaceutical Inc.		34,333	$	1,376,753	*
Vertex Pharmaceuticals Inc.		44,270		13,948,149	*
Total Biotechnology				27,321,939
Health Care Equipment & Supplies - 2.0%
Insulet Corp.		10,671		3,403,622	*
Health Care Providers & Services - 7.9%
Guardant Health Inc.		31,564		739,860	*
UnitedHealth Group Inc.		26,612		12,576,565
Total Health Care Providers & Services				13,316,425
Health Care Technology - 1.1%
Doximity Inc., Class A Shares		54,789		1,774,068	*
Life Sciences Tools & Services - 1.6%
Charles River Laboratories International Inc.		13,612		2,747,174	*
TOTAL HEALTH CARE				48,563,228
INDUSTRIALS - 7.8%
Aerospace & Defense - 4.0%
L3Harris Technologies Inc.		34,339		6,738,685
Building Products - 3.4%
Johnson Controls International PLC		94,862		5,712,590
Ground Transportation - 0.4%
Lyft Inc., Class A Shares		72,640		673,373	*
TOTAL INDUSTRIALS				13,124,648
INFORMATION TECHNOLOGY - 37.4%
Electronic Equipment, Instruments & Components - 6.5%
TE Connectivity Ltd.		83,878		11,000,600
IT Services - 2.7%
Accenture PLC, Class A Shares		5,767		1,648,266
Snowflake Inc., Class A Shares		18,397		2,838,473	*
Total IT Services				4,486,739
Semiconductors & Semiconductor Equipment - 11.8%
Broadcom Inc.		21,150		13,568,571
Wolfspeed Inc.		97,826		6,353,799	*
Total Semiconductors & Semiconductor Equipment				19,922,370
Software - 13.7%
Autodesk Inc.		41,580		8,655,293	*
CrowdStrike Holdings Inc., Class A Shares		37,643		5,166,878	*
DocuSign Inc.		31,416		1,831,553	*
Dolby Laboratories Inc., Class A Shares		10,251		875,640
HubSpot Inc.		15,211		6,521,716	*
Total Software				23,051,080

See Notes to Schedule of Investments.

    2     ClearBridge Variable Aggressive Growth Portfolio 2023 Quarterly Report

CLEARBRIDGE VARIABLE AGGRESSIVE GROWTH PORTFOLIO

Schedule of investments (unaudited) (cont’d) March 31, 2023

(Percentages shown based on Portfolio net assets)

SECURITY				SHARES		VALUE
Technology Hardware, Storage & Peripherals - 2.7%
Seagate Technology Holdings PLC					51,901	$	3,431,694
Western Digital Corp.					26,765		1,008,238	*
Total Technology Hardware, Storage & Peripherals							4,439,932
TOTAL INFORMATION TECHNOLOGY							62,900,721
MATERIALS - 1.7%
Metals & Mining - 1.7%
Freeport-McMoRan Inc.					69,296		2,834,899
TOTAL INVESTMENTS BEFORE SHORT-TERM INVESTMENTS (Cost - $94,630,318)							166,014,788
	RATE
SHORT-TERM INVESTMENTS - 1.5%
JPMorgan 100% U.S. Treasury Securities Money Market Fund, Institutional Class		4.436	%		1,732,392		1,732,392	(a)
Western Asset Premier Institutional U.S. Treasury Reserves, Premium Shares		4.617	%		742,454		742,454	(a)(b)
TOTAL SHORT-TERM INVESTMENTS (Cost - $2,474,846)							2,474,846
TOTAL INVESTMENTS - 100.1% (Cost - $97,105,164)							168,489,634
Liabilities in Excess of Other Assets - (0.1)%							(97,990	)
TOTAL NET ASSETS - 100.0%						$	168,391,644

* Non-income producing security.

(a) Rate shown is one-day yield as of the end of the reporting period.

(b) In this instance, as defined in the Investment Company Act of 1940, an “Affiliated Company” represents Portfolio ownership of at least 5% of the outstanding voting securities of an issuer, or a company which is under common ownership or control with the Portfolio. At March 31, 2023, the total market value of investments in Affiliated Companies was $742,454 and the cost was $742,454 (Note 2).

Abbreviation(s) used in this schedule:

ADR — American Depositary Receipts

This Schedule of Investments is unaudited and is intended to provide information about the Portfolio’s investments as of the date of the schedule. Other information regarding the Portfolio is available in the Portfolio’s most recent annual or semi-annual shareholder report.

See Notes to Schedule of Investments.

ClearBridge Variable Aggressive Growth Portfolio 2023 Quarterly Report         3

Notes to Schedule of Investments (unaudited)

1. Organization and significant accounting policies

ClearBridge Variable Aggressive Growth Portfolio (the “Portfolio”) is a separate diversified investment series of Legg Mason Partners Variable Equity Trust (the “Trust”). The Trust, a Maryland statutory trust, is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company.

Shares of the Portfolio may only be purchased or redeemed through variable annuity contracts and variable life insurance policies offered by the separate accounts of participating insurance companies or through eligible pension or other qualified plans.

The Portfolio follows the accounting and reporting guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 946, Financial Services – Investment Companies (“ASC 946”). The following are significant accounting policies consistently followed by the Portfolio and are in conformity with U.S. generally accepted accounting principles (“GAAP”), including, but not limited to, ASC 946.

(a) Investment valuation. Equity securities for which market quotations are available are valued at the last reported sales price or official closing price on the primary market or exchange on which they trade. The valuations for fixed income securities (which may include, but are not limited to, corporate, government, municipal, mortgage-backed, collateralized mortgage obligations and asset-backed securities) and certain derivative instruments are typically the prices supplied by independent third party pricing services, which may use market prices or broker/dealer quotations or a variety of valuation techniques and methodologies. The independent third party pricing services typically use inputs that are observable such as issuer details, interest rates, yield curves, prepayment speeds, credit risks/spreads, default rates and quoted prices for similar securities. Investments in open-end funds are valued at the closing net asset value per share of each fund on the day of valuation. When the Portfolio holds securities or other assets that are denominated in a foreign currency, the Portfolio will normally use the currency exchange rates as of 4:00 p.m. (Eastern Time). If independent third party pricing services are unable to supply prices for a portfolio investment, or if the prices supplied are deemed by the manager to be unreliable, the market price may be determined by the manager using quotations from one or more broker/dealers or at the transaction price if the security has recently been purchased and no value has yet been obtained from a pricing service or pricing broker. When reliable prices are not readily available, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded, but before the Portfolio calculates its net asset value, the Portfolio values these securities as determined in accordance with procedures approved by the Portfolio’s Board of Trustees.

Pursuant to policies adopted by the Board of Trustees, the Portfolio’s manager has been designated as the valuation designee and is responsible for the oversight of the daily valuation process. The Portfolio’s manager is assisted by the Global Fund Valuation Committee (the “Valuation Committee”). The Valuation Committee is responsible for making

4

Notes to Schedule of Investments (unaudited) (cont’d)

fair value determinations, evaluating the effectiveness of the Portfolio’s pricing policies, and reporting to the Portfolio’s manager and the Board of Trustees. When determining the reliability of third party pricing information for investments owned by the Portfolio, the Valuation Committee, among other things, conducts due diligence reviews of pricing vendors, monitors the daily change in prices and reviews transactions among market participants.

The Valuation Committee will consider pricing methodologies it deems relevant and appropriate when making fair value determinations. Examples of possible methodologies include, but are not limited to, multiple of earnings; discount from market of a similar freely traded security; discounted cash-flow analysis; book value or a multiple thereof; risk premium/yield analysis; yield to maturity; and/or fundamental investment analysis. The Valuation Committee will also consider factors it deems relevant and appropriate in light of the facts and circumstances. Examples of possible factors include, but are not limited to, the type of security; the issuer’s financial statements; the purchase price of the security; the discount from market value of unrestricted securities of the same class at the time of purchase; analysts’ research and observations from financial institutions; information regarding any transactions or offers with respect to the security; the existence of merger proposals or tender offers affecting the security; the price and extent of public trading in similar securities of the issuer or comparable companies; and the existence of a shelf registration for restricted securities.

For each portfolio security that has been fair valued pursuant to the policies adopted by the Board of Trustees, the fair value price is compared against the last available and next available market quotations. The Valuation Committee reviews the results of such back testing monthly and fair valuation occurrences are reported to the Board of Trustees quarterly.

The Portfolio uses valuation techniques to measure fair value that are consistent with the market approach and/or income approach, depending on the type of security and the particular circumstance. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable securities. The income approach uses valuation techniques to discount estimated future cash flows to present value.

5

Notes to Schedule of Investments (unaudited) (cont’d)

GAAP establishes a disclosure hierarchy that categorizes the inputs to valuation techniques used to value assets and liabilities at measurement date. These inputs are summarized in the three broad levels listed below:

• Level 1 – unadjusted quoted prices in active markets for identical investments

• Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)

• Level 3 – significant unobservable inputs (including the Portfolio’s own assumptions in determining the fair value of investments)

The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in those securities.

The following is a summary of the inputs used in valuing the Portfolio’s assets carried at fair value:

ASSETS
DESCRIPTION	QUOTED PRICES (LEVEL 1)		OTHER SIGNIFICANT OBSERVABLE INPUTS (LEVEL 2)		SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3)		TOTAL
Common Stocks†	$	166,014,788		—		—	$	166,014,788
Short-Term Investments†		2,474,846		—		—		2,474,846
Total Investments	$	168,489,634		—		—	$	168,489,634

† See Schedule of Investments for additional detailed categorizations.

2. Transactions with affiliated company

As defined by the 1940 Act, an affiliated company is one in which the Portfolio owns 5% or more of the outstanding voting securities, or a company which is under common ownership or control with the Portfolio. The following company was considered an affiliated company for all or some portion of the period ended March 31, 2023. The following transactions were effected in such company for the period ended March 31, 2023.

	Affiliate Value at December 31, 2022		Purchased				Sold				Realized Gain (Loss)		Dividend Income		Net Increase (Decrease) in Unrealized Appreciation (Depreciation)		Affiliate Value at March 31, 2023
			Cost		Shares		Proceeds		Shares
Western Asset Premier Institutional U.S. Treasury Reserves, Premium Shares	$	400,328	$	1,877,487		1,877,487	$	1,535,361		1,535,361		—	$	9,261		—	$	742,454

6